Following U.S. Stocks were among the “Top Gainers” during Friday’s trade: Regado Biosciences, (NASDAQ:RGDO), Arca Biopharma, (NASDAQ:ABIO), Life Time Fitness, (NYSE:LTM), Celladon, (NASDAQ:CLDN).
Their insights are depicted underneath:
Regado Biosciences, Inc. (RGDO), shares picked up 20.30%, and closed at $1.60. The company holds the market capitalization of 53.81M. The stock return on equity value is -387.10%, while return on assets value is -162.00%. Its 20-day moving average gained 36.99%, and the stock moved above 50-day moving average of 49.00%. The mean recommendation of analysts for this stock is 4.50.(where 1=Buy, 5=Sale).
Regado Biosciences, Inc., a biopharmaceutical corporation, focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.
ARCA biopharma, Inc. (ABIO), raised 13.97%, and closed at $0.865. The stock has the beta value of 1.71, and its volatility for the week is 8.97%, while for the month it is 10.03%. The company has the market capitalization of $18.30M. The mean recommendation of analysts for this stock is 2.00.(where 1=Buy, 5=Sale).
ARCA biopharma, Inc., a biopharmaceutical corporation, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically unique beta-blocker and mild vasodilator for the treatment of atrial fibrillation in patients with heart failure and left ventricular dysfunction. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Life Time Fitness, Inc (NYSE:LTM) enhanced 15.00%, and closed at $66.32, hitting new 52-week high of $69.13.
Life Time Fitness, Inc. (LTM), is reportedly in advanced talks to go private. KSL Capital Partners LLC, which owns hotel chains and golf and business clubs, and another unnamed private equity firm, are bidding on the gym operator, according to sources cited by the Wall Street Journal. The bidding is predictable to end next week. Shares soared 15% to 66.32.
Life Time Fitness, Inc., together with its auxiliaries, designs, builds, and operates sports and athletic, professional fitness, family recreation, and spa centers for organizations, communities, and individuals.
Celladon Corp (NASDAQ:CLDN) rose 11.84%, and closed at $24.00, hitting new 52-week high of $25.87. The company has the market capitalization of $559.20M. On the other hand the stock’s volatility for the week is 9.15%, and for the month is 6.04%. The stock price to book value is $6.08. Analyst’s mean recommendation regarding this stock is 1.50. (where 1=Buy, 5=Sale).
Celladon Corporation, a clinical-stage biotechnology corporation, focuses on developing treatments for heart failure, diabetes, and neurodegenerative diseases.
